VANCOUVER, BRITISH COLUMBIA, October 28, 2021- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF) is pleased to announce the following actions to continue the development of the Company’s PAS-403 and PAS-393 patented molecules for development…

Read More